Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.83 USD | +0.24% | +3.20% | -29.50% |
20/04 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
20/04 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.50% | 4.32B | |
+23.75% | 46.71B | |
+48.83% | 41.8B | |
-0.83% | 41.52B | |
-5.86% | 29.55B | |
+10.94% | 25.78B | |
-20.28% | 19.26B | |
+2.86% | 12.14B | |
-3.30% | 12.08B | |
+30.16% | 11.98B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Transcript : Immunovant, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 07